Home » CardioFocus Gains Approval for Excalibur Balloon
CardioFocus Gains Approval for Excalibur Balloon
The FDA granted CardioFocus’ HeartLight Excalibur balloon approval for treating paroxysmal atrial fibrillation (PAF).
The device includes a feature that optimizes the magnitude and speed of target tissue contact during pulmonary vein isolation procedures.
It also incorporates technology that allows the user to make real-time adjustments to balloon size to facilitate optimal tissue contact.
Upcoming Events
-
07May
-
14May
-
30May